{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:30Z","timestamp":1791216510891,"version":"4.1.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170885, 32370939, 82371864"],"award-info":[{"award-number":["32170885, 32370939, 82371864"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Down syndrome (DS), caused by trisomy 21, has long been viewed primarily as a neurodevelopmental disorder. However, increasing evidence indicates that it is also associated with pervasive immune dysregulation, including chronic inflammation and heightened susceptibility to autoimmunity. Here, we revisit DS from the perspective of innate immunity and suggest that it shares key features with interferon-driven, autoinflammation-like conditions. Drawing on recent multi-omics studies, we outline a mechanistic framework linking chromosome 21 gene dosage to systemic immune activation. Increased expression of interferon receptors lowers the threshold for signaling and drives persistent activation of interferon-stimulated genes (ISGs). In parallel, reduced METTL3-dependent m\n                    <jats:sup>6<\/jats:sup>\n                    A modification may stabilize pro-inflammatory transcripts and enhance innate immune sensing. These changes occur alongside chromatin accessibility remodeling enriched for AP-1\u2013associated elements, consistent with a transcriptionally primed state that amplifies inflammatory gene expression. Together, these processes form a feed-forward network involving interferon signaling, transcriptional activation, and cytokine production, providing a basis for the basal inflammatory state in DS and its high burden of immune-mediated comorbidities. This framework also highlights potential therapeutic opportunities, including JAK\u2013STAT inhibition and cytokine-targeted approaches, which may help restore immune homeostasis and inform future translational studies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1836558","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:01:08Z","timestamp":1780466468000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Revisiting down syndrome through the lens of interferonopathy and innate immune dysregulation"],"prefix":"10.3389","volume":"17","author":[{"given":"Guangfu","family":"Wang","sequence":"first","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Key Laboratory of Genetic Diseases and Functional Genomics, People\u2019s Hospital of Zhengzhou University, Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Shi","sequence":"additional","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Key Laboratory of Genetic Diseases and Functional Genomics, People\u2019s Hospital of Zhengzhou University, Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiu","family":"Liao","sequence":"additional","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Key Laboratory of Genetic Diseases and Functional Genomics, People\u2019s Hospital of Zhengzhou University, Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingtao","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Basic Medical Sciences, Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.2163","article-title":"Management of down syndrome-associated leukemias: a review","volume":"9","author":"Verma","year":"2023","journal-title":"JAMA Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq3073","article-title":"Integrated analysis of immunometabolic interactions in down syndrome","volume":"10","author":"Gillenwater","year":"2024","journal-title":"Sci Adv"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.99323","article-title":"JAK inhibition decreases the autoimmune burden in down syndrome","volume":"13","author":"Rachubinski","year":"2024","journal-title":"Elife"},{"key":"B4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.gastro.2024.02.044","article-title":"Celiac disease-related conditions: who to test","volume":"167","author":"Zingone","year":"2024","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/children11101251","article-title":"Down syndrome in children: a primary immunodeficiency with immune dysregulation","volume":"11","author":"Szczawinska-Poplonyk","year":"2024","journal-title":"Children (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1706537","article-title":"Down syndrome","volume":"382","author":"Bull","year":"2020","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/pde.14731","article-title":"Dermatologic conditions in down syndrome","volume":"38","author":"Ryan","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05736-y","article-title":"Autoimmunity in down's syndrome via cytokines, CD4 T cells and CD11c(+) B cells","volume":"615","author":"Malle","year":"2023","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1177373","article-title":"Selenium level correlates negatively with antibodies but positively with thyroid function in children with down syndrome: an Indonesian study","volume":"14","author":"Hisbiyah","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-024-08996-2","article-title":"Down syndrome and autoimmune disease","volume":"66","author":"Hom","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41577-023-00855-z","article-title":"Immune dysregulation in down syndrome","volume":"23","author":"Bordon","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-00970-0","article-title":"Down syndrome: insights into autoimmune mechanisms","volume":"19","author":"Khor","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2766021\/v1","article-title":"Characterization of autoimmune eye disease in association with Down's syndrome","volume":"38","author":"Zaki","year":"2024","journal-title":"Eye (Lond)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1391564","article-title":"Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions","volume":"17","author":"Murphy","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21060","article-title":"Aberrations in circulating inflammatory cytokine levels in patients with down syndrome: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154938","article-title":"Increased systemic inflammation in children with down syndrome","volume":"127","author":"Huggard","year":"2020","journal-title":"Cytokine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S280953","article-title":"Interferon-driven immune dysregulation in down syndrome: a review of the evidence","volume":"14","author":"Chung","year":"2021","journal-title":"J Inflammation Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2018.72","article-title":"Occurrence of hypothyroidism, diabetes mellitus, and celiac disease in emirati children with down's syndrome","volume":"33","author":"Abdulrazzaq","year":"2018","journal-title":"Oman Med J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13296","article-title":"The immune system in down syndrome: autoimmunity and severe infections","volume":"322","author":"Ramba","year":"2024","journal-title":"Immunol Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg6218","article-title":"Multidimensional definition of the interferonopathy of down syndrome and its response to JAK inhibition","volume":"9","author":"Galbraith","year":"2023","journal-title":"Sci Adv"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ph14030218","article-title":"m6A RNA methylation in systemic autoimmune diseases-a new target for epigenetic-based therapy","volume":"14","author":"Wardowska","year":"2021","journal-title":"Pharm (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00922","article-title":"A review in research progress concerning m6A methylation and immunoregulation","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102315","article-title":"Epigenetic perspectives on systemic autoimmune disease","volume":"104","author":"Karagianni","year":"2019","journal-title":"J Autoimmun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000457944","article-title":"Epigenetic alterations in cellular immunity: new insights into autoimmune diseases","volume":"41","author":"Wang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","article-title":"Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1221609","article-title":"Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications","volume":"14","author":"Song","year":"2023","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.621374","article-title":"METTL3-mediated N6-methyladenosine modification is involved in the dysregulation of NRIP1 expression in down syndrome","volume":"9","author":"Shi","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00098","article-title":"Abnormality of m6A mRNA methylation is involved in Alzheimer's disease","volume":"14","author":"Han","year":"2020","journal-title":"Front Neurosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-GMB-2023-0339","article-title":"Expression profile of inflammasome genes in individuals with down syndrome","volume":"47","author":"Arcoverde","year":"2024","journal-title":"Genet Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2022.12.003","article-title":"Mitochondrial dysfunction in down syndrome: from pathology to therapy","volume":"511","author":"Tan","year":"2023","journal-title":"Neuroscience"},{"key":"B32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mito.2022.11.003","article-title":"Therapeutics for mitochondrial dysfunction-linked diseases in down syndrome","volume":"68","author":"Ganguly","year":"2023","journal-title":"Mitochondrion"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nature23450","article-title":"m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways","volume":"548","author":"Li","year":"2017","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2018.7","article-title":"m(6)A mRNA methylation sustains Treg suppressive functions","volume":"28","author":"Tong","year":"2018","journal-title":"Cell Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41420-024-02164-3","article-title":"Methyltransferase METTL3 governs the modulation of SH3BGR expression through m6A methylation modification, imparting influence on apoptosis in the context of down syndrome-associated cardiac development","volume":"10","author":"Shi","year":"2024","journal-title":"Cell Death Discov"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0007","article-title":"Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity","volume":"13","author":"Guirguis","year":"2023","journal-title":"Cancer Discov"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.05.003","article-title":"m(6)A modification prevents formation of endogenous double-stranded RNAs and deleterious innate immune responses during hematopoietic development","volume":"52","author":"Gao","year":"2020","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03135-1","article-title":"m(6)A RNA methylation regulates the fate of endogenous retroviruses","volume":"591","author":"Chelmicki","year":"2021","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2514643122","article-title":"METTL3-dependent m6A RNA methylation suppresses aberrant mammary epithelial differentiation and neoplastic transformation","volume":"122","author":"Li","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41580-021-00430-1","article-title":"Cellular origins of dsRNA, their recognition and consequences","volume":"23","author":"Chen","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0811","article-title":"Human NLRP1 is a sensor for double-stranded RNA","volume":"371","author":"Bauernfried","year":"2021","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03269-w","article-title":"Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance","volume":"591","author":"Tigano","year":"2021","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41467-021-21904-y","article-title":"N(6)-methyladenosine RNA modification suppresses antiviral innate sensing pathways via reshaping double-stranded RNA","volume":"12","author":"Qiu","year":"2021","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s42003-021-02278-9","article-title":"Genotoxic stress in constitutive trisomies induces autophagy and the innate immune response via the cGAS-STING pathway","volume":"4","author":"Krivega","year":"2021","journal-title":"Commun Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16026","article-title":"Clinically used JAK inhibitor blunts dsRNA-induced inflammation and calcification in aortic valve interstitial cells","volume":"288","author":"Parra-Izquierdo","year":"2021","journal-title":"FEBS J"},{"key":"B46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2021.03.004","article-title":"Endogenous retrovirus expression activates type-I interferon signaling in an experimental mouse model of mesothelioma development","volume":"507","author":"Sun","year":"2021","journal-title":"Cancer Lett"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn0478","article-title":"Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling","volume":"377","author":"Chan","year":"2022","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103815","article-title":"The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammation","volume":"24","author":"Carnazzo","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112684","article-title":"METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells","volume":"42","author":"Xiao","year":"2023","journal-title":"Cell Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00452-4","article-title":"Gammadelta T cells in tissue physiology and surveillance","volume":"21","author":"Ribot","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031259","article-title":"Nuclear reorganization in hippocampal granule cell neurons from a mouse model of Down syndrome: Changes in chromatin configuration, nucleoli and Cajal bodies","volume":"22","author":"Puente-Bedia","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40659-023-00474-x","article-title":"Integration of ATAC-seq and RNA-seq identifies MX1-mediated AP-1 transcriptional regulation as a therapeutic target for Down syndrome","volume":"56","author":"Guo","year":"2023","journal-title":"Biol Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.coi.2021.06.006","article-title":"Down syndrome and type I interferon: not so simple","volume":"72","author":"Malle","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/genes11121428","article-title":"Susceptibility to heart defects in Down syndrome is associated with single nucleotide polymorphisms in HAS 21 interferon receptor cluster and VEGFA genes","volume":"11","author":"Balistreri","year":"2020","journal-title":"Genes (Basel)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00803-9","article-title":"Three copies of four interferon receptor genes underlie a mild type I interferonopathy in Down syndrome","volume":"40","author":"Kong","year":"2020","journal-title":"J ClinImmunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1908129116","article-title":"Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity","volume":"116","author":"Araya","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B57","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10875-020-00805-7","article-title":"Inborn errors of adaptive immunity in Down syndrome","volume":"40","author":"Verstegen","year":"2020","journal-title":"J ClinImmunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01399-7","article-title":"Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model","volume":"55","author":"Waugh","year":"2023","journal-title":"Nat Genet"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2025-0068OC","article-title":"Down syndrome alters type III IFN and proinflammatory airway epithelial responses to respiratory syncytial virus infection","volume":"73","author":"Chorvinsky","year":"2025","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01255-1","article-title":"Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial","volume":"398","author":"Ruperto","year":"2021","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1056\/NEJMc2202778","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. Reply","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi4888","article-title":"Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity","volume":"14","author":"Lambert","year":"2022","journal-title":"Sci Transl Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030384","article-title":"A new horizon for atopic dermatitis treatments: JAK inhibitors","volume":"13","author":"Tampa","year":"2023","journal-title":"J Pers Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107012","article-title":"Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling","volume":"26","author":"Chi","year":"2023","journal-title":"iScience"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108407","article-title":"JAK1 inhibition blocks lethal immune hypersensitivity in a mouse model of Down syndrome","volume":"33","author":"Tuttle","year":"2020","journal-title":"Cell Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab203","article-title":"JAK inhibition for treatment of psoriatic arthritis in Down syndrome","volume":"60","author":"Pham","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12969-022-00764-w","article-title":"Hemophagocytic lymphohistocytosis in trisomy 21: successful treatment with interferon inhibition","volume":"20","author":"Guild","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14051001","article-title":"A comprehensive overview of globally approved JAK inhibitors","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics"},{"key":"B69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12967-021-02932-0","article-title":"Inhibition of c-Fos expression attenuates IgE-mediated mast cell activation and allergic inflammation by counteracting an inhibitory AP1\/Egr1\/IL-4 axis","volume":"19","author":"Wang","year":"2021","journal-title":"J Transl Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00586","article-title":"Age and age-related diseases: Role of inflammation triggers and cytokines","volume":"9","author":"Rea","year":"2018","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abh0891","article-title":"The expansion of human T-bet(high)CD21(low) B cells is T cell dependent","volume":"6","author":"Keller","year":"2021","journal-title":"Sci Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.immuni.2022.01.002","article-title":"Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers","volume":"55","author":"Song","year":"2022","journal-title":"Immunity"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.09.007","article-title":"Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome","volume":"55","author":"Malle","year":"2022","journal-title":"Immunity"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00888","article-title":"Tuning the cytokine responses: An update on interleukin (IL)-4 and IL-13 receptor complexes","volume":"9","author":"Junttila","year":"2018","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578442","article-title":"JAK inhibition in Down syndrome regression disorder","volume":"395","author":"Rachubinski","year":"2024","journal-title":"J Neuroimmunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1836558\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:01:09Z","timestamp":1780466469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1836558\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":75,"alternative-id":["10.3389\/fimmu.2026.1836558"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1836558","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1836558"}}